Your browser doesn't support javascript.
loading
Clickable Albumin Nanoparticles for Pretargeted Drug Delivery toward PD-L1 Overexpressing Tumors in Combination Immunotherapy.
Gerke, Christoph; Zabala Gutierrez, Irene; Méndez-González, Diego; Cruz, M Carmen Iglesias-de la; Mulero, Francisca; Jaque, Daniel; Rubio-Retama, Jorge.
Afiliação
  • Gerke C; Department of Chemistry in Pharmaceutical Sciences, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain.
  • Zabala Gutierrez I; Ramón y Cajal Institute for Health Research (IRYCIS), Ctra. Colmenar Viejo, 28034 Madrid, Spain.
  • Méndez-González D; Department of Chemistry in Pharmaceutical Sciences, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain.
  • Cruz MCI; Ramón y Cajal Institute for Health Research (IRYCIS), Ctra. Colmenar Viejo, 28034 Madrid, Spain.
  • Mulero F; Nanomaterials for Bioimaging Group, Departamento de Fisiología, Facultad de Medicina, Universidad Autónoma de Madrid, Avda. Arzobispo Morcillo 2, 28029 Madrid, Spain.
  • Jaque D; Ramón y Cajal Institute for Health Research (IRYCIS), Ctra. Colmenar Viejo, 28034 Madrid, Spain.
  • Rubio-Retama J; Nanomaterials for Bioimaging Group, Departamento de Fisiología, Facultad de Medicina, Universidad Autónoma de Madrid, Avda. Arzobispo Morcillo 2, 28029 Madrid, Spain.
Bioconjug Chem ; 33(5): 821-828, 2022 05 18.
Article em En | MEDLINE | ID: mdl-35482594
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Antígeno B7-H1 / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Antígeno B7-H1 / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article